Literature DB >> 28325864

Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy.

Ajay K Gopal1, Brad S Kahl2, Christopher R Flowers3, Peter Martin4, Stephen M Ansell5, Esteban Abella-Dominicis6, Brian Koh6, Wei Ye6, Paul M Barr7, Gilles A Salles8, Jonathan W Friedberg7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28325864     DOI： 10.1182/blood-2016-12-757740

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  26 in total

1.  Impact of metformin use on the outcomes of newly diagnosed diffuse large B-cell lymphoma and follicular lymphoma.

Authors:  Yucai Wang; Matthew J Maurer; Melissa C Larson; Cristine Allmer; Andrew L Feldman; N Nora Bennani; Carrie A Thompson; Luis F Porrata; Thomas M Habermann; Thomas E Witzig; Stephen M Ansell; Susan L Slager; Grzegorz S Nowakowski; James R Cerhan
Journal:  Br J Haematol       Date:  2019-05-28       Impact factor: 6.998

Review 2.  Sequencing of therapies in relapsed follicular lymphoma.

Authors:  Loretta J Nastoupil; Christopher R Flowers; John P Leonard
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

3.  A diagnosis of discernment: Identifying a novel ATRX mutation in myelodysplastic syndrome with acquired α-thalassemia.

Authors:  Jedrzej Wykretowicz; Yeohan Song; Brooke McKnight; Sung Won Choi; John Magenau; Radhika Takiar; Paul El Tomb; David Ginsburg; Dale Bixby; Rami Khoriaty
Journal:  Cancer Genet       Date:  2019-01-09

Review 4.  Follicular Lymphoma: Past, Present, and Future.

Authors:  Melody R Becnel; Loretta J Nastoupil
Journal:  Curr Treat Options Oncol       Date:  2018-05-24

Review 5.  The evolving role of targeted biological agents in the management of indolent B-cell lymphomas.

Authors:  Trent Peng Wang; John Harwood Scott; Stefan Klaus Barta
Journal:  Ther Adv Hematol       Date:  2017-11-22

6.  Early Relapse in Follicular Lymphoma: High Risks and High Stakes.

Authors:  Brian K Link
Journal:  J Oncol Pract       Date:  2017-12       Impact factor: 3.840

7.  Choosing ibrutinib wisely.

Authors:  Farrukh T Awan
Journal:  Blood       Date:  2018-01-11       Impact factor: 22.113

8.  Positron-emission tomography-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma.

Authors:  Connie L Batlevi; Fushen Sha; Anna Alperovich; Ai Ni; Katy Smith; Zhitao Ying; John F Gerecitano; Paul A Hamlin; Steve M Horwitz; Erel Joffe; Anita Kumar; Matthew J Matasar; Alison J Moskowitz; Craig H Moskowitz; Ariela Noy; Colette Owens; Lia M Palomba; David Straus; Gottfried von Keudell; Andrew D Zelenetz; Venkatraman E Seshan; Stefano Luminari; Luigi Marcheselli; Massimo Federico; Anas Younes
Journal:  Eur J Cancer       Date:  2020-01-08       Impact factor: 9.162

9.  Allogeneic Transplantation for Follicular Lymphoma: Does One Size Fit All?

Authors:  Mehdi Hamadani; Mary M Horowitz
Journal:  J Oncol Pract       Date:  2017-12       Impact factor: 3.840

10.  Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma.

Authors:  Philippe Armand; Ann Janssens; Giuseppe Gritti; John Radford; John Timmerman; Antonio Pinto; Santiago Mercadal Vilchez; Peter Johnson; David Cunningham; John P Leonard; Scott J Rodig; Patricia Martín-Regueira; Anne Sumbul; Selda Samakoglu; Hao Tang; Stephen M Ansell
Journal:  Blood       Date:  2021-02-04       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.